Equity
€140,562 ▲ 22.4%
DR. E. CALLENS has made a profit without a break since 2016.
DR. E. CALLENS
Lifetime
15 annual accounts with figures on one time axispeak €113,394 (2012)
€56,962▼ 21.3%
lowest -€88,517 (2013)
€30,311▼ 30.2%
peak €140,562 (2025)
€140,562▲ 22.4%
€35,102▲ 28.8%
Board1 name since 2010
1 director
Documentsfilings and deeds
30-07-20261 day before the deadline
2025micro format
Gross margin from €72,405 to €56,962Result from €43,426 to €30,311Dividend €4,603Equity from €114,854 to €140,562Debts from €27,261 to €35,102Investments €20,721
Key points
from the 2025 annual accountsInvestments
€20,721 2.2 × depreciation
Green is investment, beige is depreciation. Machinery stands 75.9% higher than in 2024.
Filings
15 annual accounts since 2011
Two of the last ten came late. The 2018 accounts came latest: 16 days after the end of the period.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 34,691 companies had the same profile as DR. E. CALLENS has now. Each dot stands for 87 companies, two years later.
95.3%
were still trading
3.9%
stopped another way
0.7%
went bankrupt
Test of the method
The method was tested on the 497,331 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 34,691 companies, not a prediction for DR. E. CALLENS. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0830229730
Reappointment: (director)
Legal-form conversion: from private limited company (pre-2019) to private limited company · General meeting of 17-08-2023 · Gazette deed
Incorporation
published on 25-10-2010 · Gazette deed
First establishment
Olmenlaan 2, Sint-Pieters-Leeuw
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| DR. E. CALLENS Sint-Pieters-Leeuw | €175,664 | €56,962 | 80.0% | - |
| Dr. I. Van Hul Beveren-Kruibeke-Zwijndrecht | €172,103 | €59,817 | 53.6% | - |
| STELLIAN CAROLE Andenne | €179,764 | €62,444 | 75.5% | - |
| DOCTEUR ELISE AERTGEERTS Wellin | €180,530 | €54,721 | 81.5% | - |
| GL medEx Herve | €177,583 | €63,796 | 8.0% | - |
| ONCOLGIC MOBILE SERVICES Drogenbos | €211,966 | €47,565 | 83.1% | - |
| Dokters Cooreman - Dooms Leuven | €241,485 | €55,369 | 98.4% | - |
These companies have the same main activity as DR. E. CALLENS: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €172,000 and €241,000, founded between 2008 and 2012.
Official details
Source: KBO- Status
- Active since 14-10-2010Normal situation
- Activity
- Specialist medical practiceNACE 86220
- Establishment unit
- 2.193.215.4311600 Sint-Pieters-Leeuw, since 14-10-2010
- Financial year end
- 31 December
- Peppol
- Reachable since 24-11-2023
Annual accounts 2025
- ≈ €130,000estimated
- €175,664▲ 23.6%
- Filing
- Filed on 30-07-2026, 1 day before the end of the filing period
Insights on DR. E. CALLENS
DR. E. CALLENS files the micro format. That format states no turnover. The gross margin fell from €58,662 in 2011 to €56,962 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about DR. E. CALLENS
- What is the company number of DR. E. CALLENS?
- The company number of DR. E. CALLENS is 0830.229.730. The VAT number is the same number with BE in front: BE 0830.229.730.
- Where is DR. E. CALLENS based?
- The registered office is at Galgstraat 273, 1600 Sint-Pieters-Leeuw.Company details
- What does DR. E. CALLENS do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of DR. E. CALLENS?
- DR. E. CALLENS is a private limited company (BV).
- When was DR. E. CALLENS founded?
- DR. E. CALLENS was founded on 14-10-2010.
- Is DR. E. CALLENS still active?
- Yes, DR. E. CALLENS is an active enterprise in the KBO register.
- What is the turnover of DR. E. CALLENS?
- The turnover in financial year 2025 is ≈ €130,000. This figure is estimated from the gross margin of €56,962 and 32 comparable companies (NACE 862). It probably lies between €99,000 and €160,000.Financials
- Is DR. E. CALLENS profitable?
- In financial year 2025, DR. E. CALLENS made a profit of €30,311.
- Where can I find the annual accounts of DR. E. CALLENS?
- DR. E. CALLENS filed 15 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of DR. E. CALLENS due?
- DR. E. CALLENS must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.